<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859556</url>
  </required_header>
  <id_info>
    <org_study_id>10K</org_study_id>
    <nct_id>NCT04859556</nct_id>
  </id_info>
  <brief_title>Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study</brief_title>
  <official_title>Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      As technology advances, vitrectomy cutters are smaller and cut rates have become faster. In&#xD;
      this prospective study, the vitrectomy efficiency and safety between 5,000 cuts per minute&#xD;
      with 10,000 cuts per minute are compared&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose:&#xD;
&#xD;
      This study aims to compare the performance of the Alcon 25+速 UltraVit速 5000 cpm vitrectomy&#xD;
      probe versus the 25+速 Ultravit 10,000 cpm速 beveled tip, dual drive vitrectomy probe. The&#xD;
      safety profile and efficiency were compared.&#xD;
&#xD;
      Method:&#xD;
&#xD;
      Prospective, randomised study. Consecutive patients from January 2019 to August 2019&#xD;
      requiring vitrectomy for retinal detachment, epiretinal membrane, vitreous haemorrhage, and&#xD;
      macula hole were randomized into either the 10K or 5K vitrectomy group. Both groups underwent&#xD;
      vitrectomy using the proportional vacuum mode with the cut rate set at the fastest rate.&#xD;
      Patients with previous vitrectomy, other ocular diseases (glaucoma, corneal disease, or&#xD;
      significant corneal opacities), or trauma were excluded from the study. The primary endpoint&#xD;
      was vitrectomy time, while secondary endpoints included posterior vitreous detachment time,&#xD;
      intraoperative complications, and number of instruments used. The preoperative, postoperative&#xD;
      1 month and 3 month best corrected visual acuity (BCVA), and complications were recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Patients and Care provider are not able to differentiate the two different cutters since the port size are the exact same for both.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Vitrectomy time</measure>
    <time_frame>1 day</time_frame>
    <description>The time needed to remove all vitreous</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and complications</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Associated Intraoperative and post operative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of instruments used</measure>
    <time_frame>1 Day</time_frame>
    <description>The total number of additional instruments used (scissors, forceps, etc)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Vitreous Hemorrhage</condition>
  <condition>Macula Hole</condition>
  <condition>Epiretinal Membrane</condition>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>10k 25G cutter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>New cutter, with a 10,000 cut per minute blade</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5k 25G cutter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional cutter, with a 5,000 cut per minute blade</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcon 25Gauge, 10,000 cuts per minute Ultravit cutter</intervention_name>
    <description>a proprietary Vitrector from Alcon for the use on the Constellation system</description>
    <arm_group_label>10k 25G cutter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcon 25Gauge, 5,000 cuts per minute Ultravit cutter</intervention_name>
    <description>a proprietary Vitrector from Alcon for the use on the Constellation system</description>
    <arm_group_label>5k 25G cutter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consecutive patients over the age of 18 requiring vitrectomy for vitreous haemorrhage&#xD;
             (VH), epiretinal membrane (ERM), macular hole (MH), dislocated lens, rhegmatogenous&#xD;
             retinal detachment and diabetic tractional retinal detachment were randomized into the&#xD;
             study from January 2019 till August 2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with ocular comorbidities affecting surgical view including corneal opacities&#xD;
             or scar, previous vitrectomy, history of trauma or requiring silicone oil were&#xD;
             excluded from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 20, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Epiretinal Membrane</mesh_term>
    <mesh_term>Vitreous Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dipivefrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

